We are live on ! Find out more
ANIP icon

ANI Pharmaceuticals
ANIP

106 hedge funds and large institutions have $263M invested in ANI Pharmaceuticals in 2021 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 30 increasing their positions, 46 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

23% more capital invested

Capital invested by funds: $214M → $263M (+$49.1M)

4% more call options, than puts

Call options by funds: $415K | Put options by funds: $400K

0.63% less ownership

Funds ownership: 59.68% → 59.05% (-0.63%)

9% less funds holding

Funds holding: 117 → 106 (-11)

35% less repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 46

48% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 21

Holders
106
Holders Change
-11
Holders Change %
-9.4%
% of All Funds
1.86%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
11
Increased
30
Reduced
46
Closed
21
Calls
$415K
Puts
$400K
Net Calls
+$15K
Net Calls Change
-$308K

Top Buyers

1
State Street
State Street
Massachusetts
+$2.51M
2
BlackRock
BlackRock
New York
+$1.94M
3
FWSM
First Wilshire Securities Management
California
+$1.85M
4
Victory Capital Management
Victory Capital Management
Texas
+$1.81M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$1.75M

Top Sellers

1
Man Group
Man Group
United Kingdom
-$2.06M
2
Russell Investments Group
Russell Investments Group
United Kingdom
-$1.85M
3
Morgan Stanley
Morgan Stanley
New York
-$1.59M
4
Renaissance Technologies
Renaissance Technologies
New York
-$1.3M
5
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
-$1.08M
Name Holding Trade Value Shares
Change 		Change in
Stake
JP Morgan Chase
26
JP Morgan Chase
New York
$2.13M +$157K +5,024 +9%
Victory Capital Management
27
Victory Capital Management
Texas
$2.09M +$1.81M +57,793 New
Two Sigma Advisers
28
Two Sigma Advisers
New York
$2M -$50.1K -1,600 -3%
Citadel Advisors
29
Citadel Advisors
Florida
$1.78M -$580K -18,528 -27%
N
30
Nuveen
North Carolina
$1.67M +$123K +3,922 +9%
D.E. Shaw & Co
31
D.E. Shaw & Co
New York
$1.4M +$385K +12,286 +46%
RhumbLine Advisers
32
RhumbLine Advisers
Massachusetts
$1.26M +$36K +1,150 +3%
HSA
33
Hussman Strategic Advisors
Maryland
$1.1M – – –
CS
34
Credit Suisse
Switzerland
$972K -$131K -4,199 -13%
Legal & General Group
35
Legal & General Group
United Kingdom
$963K +$8.89K +284 +1%
Wells Fargo
36
Wells Fargo
California
$952K -$291K -9,303 -26%
New York State Teachers Retirement System (NYSTRS)
37
New York State Teachers Retirement System (NYSTRS)
New York
$838K -$21.9K -700 -3%
Swiss National Bank
38
Swiss National Bank
Switzerland
$810K – – –
GC
39
Globeflex Capital
California
$792K – – –
AllianceBernstein
40
AllianceBernstein
Tennessee
$783K +$70.4K +2,250 +12%
AQR Capital Management
41
AQR Capital Management
Connecticut
$752K -$420K -13,424 -39%
Public Sector Pension Investment Board (PSP Investments)
42
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$718K -$45.1K -1,440 -7%
California Public Employees Retirement System
43
California Public Employees Retirement System
California
$698K -$56.4K -1,800 -9%
DC
44
Defender Capital
North Carolina
$687K +$125K +4,000 +27%
PPA
45
Parametric Portfolio Associates
Washington
$686K +$33.3K +1,064 +6%
1CM
46
1492 Capital Management
Wisconsin
$657K -$168K -5,355 -23%
Barclays
47
Barclays
United Kingdom
$601K +$38.5K +1,230 +8%
PCM
48
Perkins Capital Management
Minnesota
$530K +$459K +14,666 New
BGIM
49
Brandywine Global Investment Management
Pennsylvania
$529K -$6.26K -200 -1%
Brown Advisory
50
Brown Advisory
Maryland
$517K -$5.64K -180 -1%
1
2
3 4 5

ANIP Hedge Fund Activity: Q1 2021 in Review

106 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in ANI Pharmaceuticals (ANIP) for Q1 2021, worth a combined $263M — up 23% from $214M a quarter earlier.

Sellers outnumbered buyers: 21 funds closed out of ANIP and 11 opened new positions — a net loss of 10 holders — while 46 trimmed existing stakes and 30 added.

The largest buyer was State Street, adding an estimated $2.51M. The largest seller was Man Group, exiting entirely with an estimated $2.06M sold.

  • 106 institutional investors held ANI Pharmaceuticals (ANIP) as of Q1 2021, down from 117 in Q4 2020.
  • Funds reported $263M of ANI Pharmaceuticals stock for Q1 2021, up 23% quarter-over-quarter.
  • 11 funds opened new ANI Pharmaceuticals positions in Q1 2021 and 21 closed out, a net change of -10 holders.
  • The largest ANI Pharmaceuticals buyer in Q1 2021 was State Street, an estimated $2.51M added.
  • The largest ANI Pharmaceuticals seller in Q1 2021 was Man Group, an estimated $2.06M sold.

Based on aggregated 13F filings for Q1 2021.